Colocalized radiofrequency and pulsed field ablation of incessant ventricular tachycardia with suspected intramural circuit in ischaemic cardiomyopathy using a 3.5 mm single-tip catheter under eCPR: a case report

在心肺复苏(eCPR)下,使用3.5 mm单尖导管对缺血性心肌病伴疑似心肌内环路的持续性室性心动过速进行射频消融和脉冲场联合消融:病例报告

阅读:2

Abstract

BACKGROUND: Incessant ventricular tachycardia (VT) in advanced ischaemic cardiomyopathy is a life-threatening condition, particularly when maintained by deep intramyocardial scar channels that can be difficult to eliminate with conventional radiofrequency (RF) ablation. Pulsed-field ablation (PFA) is a non-thermal, myocardium-selective modality with the potential to target arrhythmogenic tissue while minimizing collateral injury. CASE SUMMARY: We report a case of incessant VT in a 60-year-old man with severe ischaemic cardiomyopathy in whom acute VT termination and final non-inducibility were achieved using a sequential dual-energy strategy combining RF and PFA delivered with a 3.5 mm open-irrigated catheter capable of both modalities [Dual Energy THERMOCOOL SMARTTOUCH™ (DE-STSF), Johnson & Johnson MedTech]. The procedure was performed under extracorporeal cardiopulmonary resuscitation (eCPR) via veno-arterial extracorporeal membrane oxygenation (VA-ECMO) during electrical storm. Despite VT termination and arrhythmia control, the patient died on Day 5 from refractory shock with progressive multiorgan failure. DISCUSSION: This case supports the feasibility of colocalized sequential RF-PFA ('energy stacking') as an adjunct strategy for suspected intramural post-infarction VT substrate in selected high-risk patients. Supported by VA-ECMO, this dual-energy strategy achieved acute VT non-inducibility and arrhythmia control, despite an unfavourable overall clinical outcome. Further systematic evaluation is warranted to define the incremental role of dual-energy lesion delivery in ventricular substrates.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。